ArticlePloS one2014

The sodium-glucose co-transporter 2 inhibitor empagliflozin improves diabetes-induced vascular dysfunction in the streptozotocin diabetes rat model by interfering with oxidative stress and glucotoxicity.

Matthias Oelze et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.